Shares of Verici Dx plc (LON:VRCI – Get Free Report) fell 6.7% during mid-day trading on Friday . The stock traded as low as GBX 0.35 and last traded at GBX 0.35. Approximately 22,440 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 1,715,658 shares. The stock had previously closed at GBX 0.38.
Verici Dx Stock Down 6.7%
The business has a fifty day simple moving average of GBX 0.43 and a 200 day simple moving average of GBX 0.57. The firm has a market cap of £5.30 million, a price-to-earnings ratio of -0.12 and a beta of 1.26. The company has a debt-to-equity ratio of 11.36, a current ratio of 0.91 and a quick ratio of 8.49.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
